软体动物毒素在心血管疾病管理中的作用
1Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Thandalam, Chennai, India.
Natural product research
|July 5, 2024
概括
类毒素因其抗高血压和心脏保护作用,对治疗心血管疾病 (CVD) 有望. 对这些天然化合物的进一步研究可能会产生针对心血管疾病的新疗法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 海洋生物学 海洋生物学
- 心血管医学 心血管医学
背景情况:
- 心血管疾病 (CVD) 是一个日益严重的全球健康问题.
- 目前对心血管疾病的治疗策略存在局限性,需要新的治疗方法.
- 软体动物产生各种各样的生物活性,具有潜在的治疗应用.
研究的目的:
- 突出软体动物衍生的潜力,作为心血管疾病 (CVD) 的创新治疗方法.
- 探索这些的特定特性,包括抗高血压,抗血栓和心脏保护作用.
- 讨论基工程在克服交付挑战方面的影响.
主要方法:
- 审查关于软体动物衍生和它们的生物活动的现有文献.
- 鉴定特定的类,如共毒素,其已证明对心血管点的影响.
- 讨论用于治疗开发的质工程的进展.
主要成果:
- 软体动物呈现出有希望的抗高血压特性,以毒素为例,向电压通道.
- 这些具有潜在的抗血栓和心脏保护作用.
- 体工程为增强生物可用性和稳定性提供了解决方案.
结论:
- 类毒素代表了新型心血管疾病治疗的有希望的途径.
- 进一步的研究和跨学科的合作对于充分阐明它们的治疗潜力和安全性至关重要.
- 这些天然化合物可能会导致CVD管理的突破性进展.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Heart Failure Drugs: Inotropic Agents
564
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
564
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
74
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
74
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
486
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
486
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
666
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
666


